House advances bill combating synthetic drug trafficking

House advances bill combating synthetic drug trafficking

A bill that would increase global cooperation in the fight against synthetic drug trafficking passed the U.S. House of Representatives on Nov. 18.

Introduced by U.S. Rep. David Trone (D-MD) and co-sponsored by Dave Joyce (R-OH), the bill, “Fighting Emerging Narcotics Through Additional Nations to Yield Lasting (FENTANYL) Results Act,” is endorsed by Mothers Against Prescription Drug Abuse, the Partnership to End Addiction, the Addiction Policy Forum and the Community Anti-Drug Coalition.

“Over the past several years, I’ve been proud of Congress’ bipartisan work to combat the opioid crisis and prevent the trafficking of lethal, illicit drugs,” Joyce said. “But sadly, that progress is slipping away. Fatal overdoses hit a record high last year, and recent data from the CDC shows that more than half of those deaths involved synthetic opioids like fentanyl. We can and must attack this crisis from every angle, and this bipartisan legislation will help us do just that. I’m proud to be a cosponsor of the FENTANYL Results Act and look forward to seeing it become law so that we can continue to improve global cooperation in the fight against synthetic drug trafficking.”

The bill would require the U.S. Secretary of State to prioritize efforts to combat the international flow of fentanyl and other synthetic narcotics into the U.S. The bill would also authorize two programs at the State Department specifically for building foreign law enforcement capacity to detect synthetic drugs and to utilize an international drug demand reduction expert exchange program and would require the State Department to add synthetic opioids to its International Narcotics Control Strategy Report.